- Home
- JZXN vs BCTX Comparison
JZXN vs BCTX Comparison
Compare JZXN & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JZXN
- BCTX
- Stock Information
- Founded
- JZXN 2019
- BCTX 2014
- Country
- JZXN China
- BCTX Canada
- Employees
- JZXN N/A
- BCTX N/A
- Industry
- JZXN Retail-Auto Dealers and Gas Stations
- BCTX Biotechnology: Pharmaceutical Preparations
- Sector
- JZXN Consumer Discretionary
- BCTX Health Care
- Exchange
- JZXN Nasdaq
- BCTX Nasdaq
- Market Cap
- JZXN 23.5M
- BCTX 21.8M
- IPO Year
- JZXN 2021
- BCTX N/A
- Fundamental
- Price
- JZXN $0.38
- BCTX $11.20
- Analyst Decision
- JZXN
- BCTX Strong Buy
- Analyst Count
- JZXN 0
- BCTX 1
- Target Price
- JZXN N/A
- BCTX $40.00
- AVG Volume (30 Days)
- JZXN 8.6M
- BCTX 84.8K
- Earning Date
- JZXN 03-05-2026
- BCTX 10-28-2025
- Dividend Yield
- JZXN N/A
- BCTX N/A
- EPS Growth
- JZXN N/A
- BCTX N/A
- EPS
- JZXN N/A
- BCTX N/A
- Revenue
- JZXN $97,465.00
- BCTX N/A
- Revenue This Year
- JZXN N/A
- BCTX N/A
- Revenue Next Year
- JZXN N/A
- BCTX N/A
- P/E Ratio
- JZXN N/A
- BCTX N/A
- Revenue Growth
- JZXN N/A
- BCTX N/A
- 52 Week Low
- JZXN $0.30
- BCTX $6.00
- 52 Week High
- JZXN $7.82
- BCTX $190.50
- Technical
- Relative Strength Index (RSI)
- JZXN 35.35
- BCTX 63.28
- Support Level
- JZXN $0.30
- BCTX $12.50
- Resistance Level
- JZXN $0.43
- BCTX $12.97
- Average True Range (ATR)
- JZXN 0.18
- BCTX 0.80
- MACD
- JZXN -0.04
- BCTX -0.19
- Stochastic Oscillator
- JZXN 4.02
- BCTX 49.76
About JZXN Jiuzi Holdings Inc.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its operating segments are propretaey product; and resale of sourced Equipment and accessories from third party products. The company generates a majority of its revenue from the propretaey product segment. Geographically, the firm operates in China.
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.